Clinical Trial Update: Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205 [Phase 1]

View source ↗

Summary

Phase 1 trial updating immunogenicity of AIDSVAX B/E and MVA/HIV62B vaccines in HIV-uninfected adults previously exposed to MVA/HIV62B, with completed status an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• AIDSVAX B/E
• MVA/HIV62B (Modified Vaccinia Ankara expressing HIV-1 antigens 62B)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2021-04-01